-
1دورية أكاديمية
المؤلفون: Alene KA; School of Public Health, Curtin University, Bentley, WA, Australia.; Research School of Population Health, College of Health and Medicine, The Australian National University, Canberra, ACT, Australia.; Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.; Telethon Kids Institute, Perth, WA, Australia., Viney K; Research School of Population Health, College of Health and Medicine, The Australian National University, Canberra, ACT, Australia.; Department of Public Health Sciences, Centre for Global Health, Karolinska Institutet, Stockholm, Sweden., McBryde ES; Australian Institute of Tropical Health and Medicine, James Cook University, Townsville, QLD, Australia., Gray DJ; Research School of Population Health, College of Health and Medicine, The Australian National University, Canberra, ACT, Australia., Melku M; School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia., Clements ACA; School of Public Health, Curtin University, Bentley, WA, Australia.; Telethon Kids Institute, Perth, WA, Australia.
المصدر: Transboundary and emerging diseases [Transbound Emerg Dis] 2019 Jul; Vol. 66 (4), pp. 1611-1618. Date of Electronic Publication: 2019 Apr 15.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: Blackwell Verlag Country of Publication: Germany NLM ID: 101319538 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-1682 (Electronic) Linking ISSN: 18651674 NLM ISO Abbreviation: Transbound Emerg Dis Subsets: MEDLINE
مواضيع طبية MeSH: Antitubercular Agents/*pharmacology , HIV Infections/*complications , Mycobacterium tuberculosis/*isolation & purification , Tuberculosis, Multidrug-Resistant/*epidemiology, Adult ; Case-Control Studies ; Demography ; Ethiopia/epidemiology ; Female ; Hospitals ; Humans ; Isoniazid/pharmacology ; Logistic Models ; Male ; Middle Aged ; Mycobacterium tuberculosis/drug effects ; Odds Ratio ; Regression Analysis ; Rifampin/pharmacology ; Risk Factors ; Tuberculosis, Multidrug-Resistant/complications ; Tuberculosis, Multidrug-Resistant/microbiology ; Young Adult